HIV conference spotlights women's concerns. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

HIV conference spotlights women's concerns. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Alert. 1995 Apr;10(4):54-7. Unique Identifier : AIDSLINE AIDS/95700226

Abstract: The HIV Infection in Women: Setting a New Agenda conference in Washington, DC, brought together researchers, providers, and HIV- positive women to discuss AIDS among women. The U.S. Public Health Service announced draft guidelines on counseling and testing of all pregnant women for HIV. These guideline were made in response to the 1994 clinical finding of ACTG 076 that the use of zidovudine (AZT, Retrovir) significantly decreases transmission of HIV from mothers to newborns. Other conference attendees expressed mistrust of AZT as a safe and effective treatment and criticized the Food and Drug Administration (FDA) for slow approval of AIDS drugs and for failing to include women in clinical trials. A representative of the Clinton administration told attendees that approximately $20 million has been allocated in the 1995 National Institutes of Health budget to study female control barriers, and an additional $724 million has been proposed for the Ryan White Care Act. In addition, participants heard information on six ongoing women's cohort studies. AIDS is now the fourth leading cause of death among American women ages 25 to 44.

Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY Clinical Trials Female Guidelines Human HIV Infections/EPIDEMIOLOGY Pregnancy Pregnancy Complications, Infectious Prevalence *Women's Health NEWSLETTER ARTICLE
951030
M95A0958

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .